	US 12,256,763 B2
	Method for enhancing athletic abilities
Hiroto Morita, Moriya (JP); Chie Kano, Moriya (JP); Teppei Nakamura, Moriya (JP); and Makiko Onishi, Moriya (JP)
Assigned to Asahi Group Holdings, Ltd., Tokyo (JP)
Appl. No. 17/442,378
Filed by Asahi Group Holdings, Ltd., Tokyo (JP)
PCT Filed Mar. 13, 2020, PCT No. PCT/JP2020/011262 § 371(c)(1), (2) Date Sep. 23, 2021, PCT Pub. No. WO2020/203195, PCT Pub. Date Oct. 8, 2020.
Claims priority of application No. 2019-067505 (JP), filed on Mar. 29, 2019.
Prior Publication US 2022/0192245 A1, Jun. 23, 2022
Int. Cl. A23L 33/125 (2016.01); A61K 31/724 (2006.01); A61P 3/02 (2006.01)

CPC A23L 33/125 (2016.08) [A61K 31/724 (2013.01); A61P 3/02 (2018.01)]

9 Claims

1. A method of enhancing athletic ability, comprising administering α-cyclodextrin to a human subject in need thereof, wherein said α-cyclodextrin is administered in an amount from 0.01 mg/kg body weight to 50 mg/kg body weight per day.